This is the most important conclusion drawn from the post-hoc analysis of the MOVES clinical trial which was presented today at the annual meeting of the American Academy of Rheumatology.
This certification is a recognition of the excellence standards achieved by Bioiberica in their effort to improve energy efficiencyDuring the next three years, our company has set the following objectives: 15% reduction in energy consumption per production unit, 10% of the energy will come from by-product use, and 5% from renewable energies
Bioiberica presented their products for crop quality improvement and environmentally-friendly crop protection
Bioibericas Veterinary Division was present at the 7th Southern European Veterinary Conference (SEVC), held from 16 to 18 October in Barcelona.